All these effects of MET, MMP- 2 downregulation and migratory-invasive behavior inhibition, were also obtained in the human mammary cancer T47-D cells where its natural high RAC3 expression was stably inhibited by an shRAC3 RNA (data not shown), demonstrating that is not exclusive of colon cancer. Here, MET is linked to malignant colon neoplasm.